(資料圖片僅供參考)

PhotoshowsCOVID-19antigenrapidtestkits(Photo:ChinaNewsService/ZhangHengwei)

(ECNS)--ChinawilllaunchatargetedcampaignfromJanuarytoJunetosecurestablepricesandgoodqualityofCOVID-19relateddrugsandmedicalsupplies,accordingtoanofficialofthecountry"stopmarketwatchdog.

LuoWen,headoftheStateAdministrationforMarketRegulation,stressedonWednesdaythatChinawillsparenoeffortstocrackdownonpricegouging,hoarding,illegaladvertising,falsepublicity,counterfeitgoods,andotherviolationsregardinganti-COVID-19supplies.

GiventhatChinawilldowngrademanagementofCOVID-19toClassBfromJan.8,2023,thesupplyanddemandofrelateddrugsandmedicalsupplieswillbekeptintightbalance,Luosaid.

Overthepastmonth,priceandqualitycomplaintsaboutanti-COVIDdrugsreceivedbythe12315consumerdisputeresolutionplatformhaveincreasedby528percentfromthepreviousmonth,andthenumbermaycontinuetoriseinthefuture,headded.

Atthiscriticaljuncture,thetargetedcrackdownissignificanttothecountry"santi-COVIDmeasures,people"slivelihoodandmarketstability,hesaid.

Hesuggestedthelaunchofanemergencyresponsemechanismandimmediateresponseduringthecampaign.